1. Home
  2. BCO vs MLTX Comparison

BCO vs MLTX Comparison

Compare BCO & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCO
  • MLTX
  • Stock Information
  • Founded
  • BCO 1859
  • MLTX 2021
  • Country
  • BCO United States
  • MLTX Switzerland
  • Employees
  • BCO N/A
  • MLTX N/A
  • Industry
  • BCO Oil Refining/Marketing
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCO Consumer Discretionary
  • MLTX Health Care
  • Exchange
  • BCO Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • BCO 4.1B
  • MLTX 3.4B
  • IPO Year
  • BCO N/A
  • MLTX N/A
  • Fundamental
  • Price
  • BCO $91.83
  • MLTX $52.17
  • Analyst Decision
  • BCO Strong Buy
  • MLTX Strong Buy
  • Analyst Count
  • BCO 3
  • MLTX 9
  • Target Price
  • BCO $120.50
  • MLTX $77.43
  • AVG Volume (30 Days)
  • BCO 304.2K
  • MLTX 190.2K
  • Earning Date
  • BCO 11-06-2024
  • MLTX 11-07-2024
  • Dividend Yield
  • BCO 1.07%
  • MLTX N/A
  • EPS Growth
  • BCO N/A
  • MLTX N/A
  • EPS
  • BCO 2.64
  • MLTX N/A
  • Revenue
  • BCO $4,993,300,000.00
  • MLTX N/A
  • Revenue This Year
  • BCO $3.72
  • MLTX N/A
  • Revenue Next Year
  • BCO $4.41
  • MLTX N/A
  • P/E Ratio
  • BCO $34.52
  • MLTX N/A
  • Revenue Growth
  • BCO 3.60
  • MLTX N/A
  • 52 Week Low
  • BCO $79.03
  • MLTX $37.55
  • 52 Week High
  • BCO $115.91
  • MLTX $64.98
  • Technical
  • Relative Strength Index (RSI)
  • BCO 32.36
  • MLTX 49.27
  • Support Level
  • BCO $93.96
  • MLTX $50.60
  • Resistance Level
  • BCO $97.22
  • MLTX $58.26
  • Average True Range (ATR)
  • BCO 2.32
  • MLTX 3.00
  • MACD
  • BCO -0.22
  • MLTX -0.29
  • Stochastic Oscillator
  • BCO 4.73
  • MLTX 24.35

About BCO Brinks Company (The)

The Brink's Co is a Global provider of secure logistics and security solutions for cash and other valuables. In 2020, the company acquired the U.K.-based G4S that reorganized its operating segments to be North America, Latin America, Europe, and Rest of World. It generates maximum revenue from the North America segment, namely from its core business of cash-in-transit and ATM services. The Latin America and Europe segments trail North America in revenue earnings with the Brinks Global Services line of business that specializes in the secure transportation of high-valued commodities, such as jewelry, precious metals, banknotes, and electronics. Brink's customer base includes financial institutions, retails, government agencies, mints, and other commercial businesses.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Share on Social Networks: